|
|
Volumn 95, Issue 6, 2003, Pages 425-426
|
|
FDA guidelines on race and ethnicity: Obstacle or remedy?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
ANTIDEPRESSANT AGENT;
ANTIHYPERTENSIVE AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
NEUROLEPTIC AGENT;
ASIAN;
CAUCASIAN;
CLINICAL TRIAL;
DATA ANALYSIS;
DIETARY INTAKE;
DRUG EFFICACY;
DRUG RESPONSE;
DRUG SAFETY;
ENVIRONMENTAL EXPOSURE;
ENVIRONMENTAL FACTOR;
ETHNIC DIFFERENCE;
ETHNIC GROUP;
FOOD AND DRUG ADMINISTRATION;
HEALTH CARE POLICY;
HEPATITIS C;
HEPATITIS C VIRUS;
HEREDITY;
HUMAN;
IMMIGRATION;
INFORMATION PROCESSING;
MARRIAGE;
MEDICAL RESEARCH;
NEGRO;
NOTE;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RACE DIFFERENCE;
SOCIAL ASPECT;
SOCIAL STATUS;
STANDARDIZATION;
TREATMENT OUTCOME;
UNITED STATES;
|
|
EID: 0037454228
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/95.6.425 Document Type: Note |
|
Times cited : (6)
|
|
References (0)
|